Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha 1-Antitrypsin | 8 | 2025 | 94 | 1.520 |
Why?
|
| Hepatocytes | 3 | 2020 | 218 | 0.720 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 4 | 2025 | 69 | 0.680 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2023 | 454 | 0.660 |
Why?
|
| Genetic Therapy | 7 | 2025 | 791 | 0.570 |
Why?
|
| Dependovirus | 7 | 2025 | 709 | 0.430 |
Why?
|
| Genetic Vectors | 7 | 2025 | 879 | 0.380 |
Why?
|
| Mice, Transgenic | 5 | 2025 | 1277 | 0.230 |
Why?
|
| Gene Editing | 3 | 2025 | 322 | 0.230 |
Why?
|
| Liver Diseases | 1 | 2025 | 156 | 0.210 |
Why?
|
| Primates | 1 | 2024 | 51 | 0.210 |
Why?
|
| Lung Diseases | 1 | 2025 | 183 | 0.210 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2187 | 0.190 |
Why?
|
| Transplantation, Heterologous | 2 | 2020 | 229 | 0.190 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 525 | 0.180 |
Why?
|
| Mice | 9 | 2025 | 10846 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 361 | 0.150 |
Why?
|
| Mice, SCID | 1 | 2020 | 519 | 0.150 |
Why?
|
| Alleles | 1 | 2020 | 448 | 0.140 |
Why?
|
| Animals | 10 | 2025 | 20666 | 0.140 |
Why?
|
| Enzyme Assays | 1 | 2017 | 15 | 0.130 |
Why?
|
| Reference Standards | 1 | 2017 | 73 | 0.130 |
Why?
|
| Transgenes | 1 | 2017 | 187 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2020 | 2109 | 0.130 |
Why?
|
| Transduction, Genetic | 2 | 2015 | 238 | 0.130 |
Why?
|
| Liver | 3 | 2015 | 855 | 0.100 |
Why?
|
| Gene Silencing | 2 | 2017 | 400 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 525 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 297 | 0.100 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2012 | 14 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 63512 | 0.090 |
Why?
|
| Mitochondrial Diseases | 1 | 2012 | 22 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2012 | 50 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 321 | 0.090 |
Why?
|
| Mutation | 4 | 2025 | 2615 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2009 | 37 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2017 | 687 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2009 | 81 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2009 | 64 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2009 | 94 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 770 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1147 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 741 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 36 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 53 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2024 | 612 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 113 | 0.050 |
Why?
|
| Gene Expression | 2 | 2017 | 840 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 459 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 327 | 0.040 |
Why?
|
| Graft Survival | 1 | 2017 | 290 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2578 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 167 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2015 | 101 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2015 | 256 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 367 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2012 | 9 | 0.020 |
Why?
|
| Carnitine | 1 | 2012 | 19 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 32 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 292 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1471 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 202 | 0.020 |
Why?
|
| Male | 2 | 2024 | 29927 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 219 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2009 | 19 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2009 | 98 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1331 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 149 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 130 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 1207 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 664 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1617 | 0.010 |
Why?
|